FTSE 250 Index inclusion

By

Regulatory News | 16 Sep, 2019

Updated : 13:23

RNS Number : 4776M
GCP Student Living PLC
16 September 2019
 

GCP Student Living plc

(the "Company" or "GCP Student", together with its subsidiaries the "Group")

LEI: 2138004J4ID66FK38H25

FTSE 250 Index inclusion

The Board of GCP Student, the UK's first REIT focused on student residential assets, is pleased to announce that FTSE Russell has confirmed that the Company will be added to the FTSE 250 Index with effect from 18 September 2019.

For further information please contact:

Gravis Capital Management Limited


+44 (0)20 3405 8500

Nick Barker

nick.barker@graviscapital.com


Dion Di Miceli

dion.dimiceli@graviscapital.com


Stifel Nicolaus Europe Limited


+44 (0)20 7710 7600

Neil Winward

neil.winward@stifel.com


Mark Young

mark.young@stifel.com


Tom Yeadon

tom.yeadon@stifel.com


Buchanan / Quill


+44 (0)20 7466 5000

Helen Tarbet

helent@buchanan.uk.com


Henry Wilson  

henryw@buchanan.uk.com


About GCP Student

The Company was the first student accommodation REIT in the UK, investing in modern, purpose-built, private student residential accommodation and teaching facilities. Its investments are located primarily in and around London where the Investment Manager believes the Company is likely to benefit from supply and demand imbalances for student residential accommodation.

GCP Student's property portfolio comprises eleven assets with c.4,100 beds, including one asset which is expected to complete construction for the 2020/21 academic year. At 30 June 2019, its property portfolio was valued at £921.6 million.

The Company's standing properties are predominantly occupied by international students and offer high specification facilities and hotel-level concierge type services which the Investment Manager believes are attractive to overseas students.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKADDBBKDFCD

Last news